Inhibition of topoisomerase I by naphthoquinone derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 23, 1998, Pages 3385-3390

  Plyta, Zoi F ^a   Li, Tianhu ^b   Papageorgiou, Vassilios P ^c   Mellidis, Antonios S ^c   Assimopoulou, Andreana N ^c   Pitsinos, Emmanuel N ^a   Couladouros, Elias A ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; ALKANNIN; DNA TOPOISOMERASE; SHIKONIN;

ALKYLATION; ARTICLE; DERIVATIZATION; DNA STRAND BREAKAGE; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; PROTEIN DOMAIN; REOXYGENATION;

EID: 0008742582     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00600-3     Document Type: Article

References (18)

1. 1. Webb, J. L. In Enzyme and Metabolic Inhibitors; Academic Press: New York, 1996; Vol. 3, pp. 421-594.
2. 2. Miller, M. G.; Rodgers, A.; Cohen, G. M. Biochem. Pharmacol. 1986, 35, 1177.
3. 3. (a) Moore, H. W. Science 1977, 197, 527.
4. (b) Alternatively, as one of the referees pointed out, acylation could potentate the inhibitory effect to a great extent through increase of the binding force. Although increase in enzyme affinity can not be ruled out, the binding site will have to be very tolerant to acyl groups of different steric requirements.
5. 4. Barrett, J. F.; Gootz, T. D.; McGuirk, P. R.; Farrell, C. A.; Sokolowski, S. A. Antimicrob. Agents Chemother. 1989, 33, 1697.
6. 5. Foglesong, P. D.; Reckord, C.; Swink, S. Cancer Chemother. Pharmacol. 1992, 30, 123.
7. 6. D'Arpa, P.; Liu, L. F. Biochim. Biophys. Acta 1989, 989, 163.
8. 7. Fesen, M. R.; Kohn, K. W.; Leteurtre, F.; Pommier, Y. Proc. Natl. Acad. Sci. USA 1993, 90, 2399.
9. 8. Brinkworth, R. I.; Fairlie, D. P. Biochim. Biophys Acta 1995, 1253, 5.
10. 9. Fujii, N.; Yamashita, Y.; Arima, Y.; Nagashima, M.; Nakano, H. Antimicrob. Agents Chemother. 1992, 36, 2589.
11. 10. Moullet, O.; Dreyer, J. -L. Biochem. J. 1994, 300, 99.
12. 11. Ahn, B.-Z.; Baik, K.-U.; Kweon, G.-R.; Lim, K.; Hwang, B.-D. J. Med. Chem. 1995, 38, 1044.
13. 12. Smith C. E.; Ruttledge T.; Zeng, Z.; O'Malley, R. C.; Lynn, D. G. Proc. Natl. Acad. Sci. USA 1996, 93, 6986.
14. 13. Zahn K.; Ochwat P. Ann. 1928, 462, 72; see also: Fieser L. F J.Am.Chem.Soc. 1928, 50, 439.
15. 13. Zahn K.; Ochwat P. Ann. 1928, 462, 72; see also: Fieser L. F J.Am.Chem.Soc. 1928, 50, 439.
16. 14. Couladouros E. A.; Plyta Z. F.; Papageorgiou V. P. J. Org. Chem. 1996, 61, 3031.
17. 15. Couladouros E. A.; Plyta Z. F.; Haroutounian S. A.; Papageorgiou V. P. J. Org. Chem. 1997, 62, 6.
18. 16. Couladouros E. A.; Plyta Z. F.; Iliadis T.; Roussis V.; Papageorgiou V. P. J. Heterocyclic Chem. 1996, 33, 709.